Skip to main content

Table 2 Relationship between NUSAP1 and clinical data

From: Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors

Clinical parameters L-NUSAP1 (n = 373, %) H-NUSAP1 (n = 124, %) p-value
Age (years)
 < 55 249 (66.8) 83 (66.9) 1
 ≥ 55 124 (33.2) 41 (33.1)
Gender
 Female 271 (72.7) 92 (74.2) 0.816
 Male 102 (27.3) 32 (25.8)
Stage
 I 208 (56.1) 73 (58.9) 0.063
 II 45 (12.1) 6 (4.8)
 III 82 (22.1) 27 (21.8)
 IV 36 (9.7) 18 (14.5)
 NA 2 0  
Metastasis
 M0 205 (97.2) 71 (95.9) 0.7
 M1 6 (2.8) 3 (4.1)
 NA 162 50
N classification
 N0 182 (54.8) 44 (38.3) 0.002
 N1 150 (45.2) 71 (61.7)
 NA 41 9
T classification
 T1 112 (30.1) 30 (24.4) 0.095
 T2 129 (34.7) 36 (29.3)
 T3 118 (31.7) 48 (39.0)
 T4 13 (3.5) 9 (7.3)
 NA 1 1  
Pathologic type
 Classical 256 (68.6) 97 (78.2) 0.012
 Follicular 88 (23.6) 14 (11.3)
 Tall cell 23 (6.2) 12 (9.7)
 Others 6 (1.2) 1 (0.2)
BRAF
 Wild-type 150 (41.4) 46 (38.3) 0.592
 Mutated 212 (58.6) 74 (61.7)
 NA 11 4
RAS
 Wild-type 330 (91.2) 113 (94.2) 0.34
 Mutated 32 (8.8) 7 (5.8)
 NA 11 4